149 related articles for article (PubMed ID: 22831783)
1. Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
Vidal D; Altés J; Smandia JA
Actas Dermosifiliogr; 2013 Jan; 104(1):89-90. PubMed ID: 22831783
[No Abstract] [Full Text] [Related]
2. Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus.
Creel N; Werth V
J Drugs Dermatol; 2005; 4(2):225-7. PubMed ID: 15776783
[TBL] [Abstract][Full Text] [Related]
3. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
4. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
5. Pigmented oral mucosa due to quinacrine.
López-Jornet P; Pons-Fuster A
N Y State Dent J; 2011 Nov; 77(6):49-51. PubMed ID: 22338819
[TBL] [Abstract][Full Text] [Related]
6. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
[TBL] [Abstract][Full Text] [Related]
7. Current treatment of cutaneous lupus erythematosus.
Werth V
Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin.
Suess A; Sticherling M
Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611
[TBL] [Abstract][Full Text] [Related]
9. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
10. Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area.
Martin TJ; Sharp I
Br J Oral Maxillofac Surg; 2004 Aug; 42(4):351-3. PubMed ID: 15225957
[TBL] [Abstract][Full Text] [Related]
11. Mepacrine pigmentation in systemic lupus erythematosus. New data from an ultrastructural, biochemical and analytical electron microscopic investigation.
Leigh IM; Kennedy CT; Ramsey JD; Henderson WJ
Br J Dermatol; 1979 Aug; 101(2):147-53. PubMed ID: 486320
[TBL] [Abstract][Full Text] [Related]
12. A case of a focal oedematous reaction induced by rituximab overlying lupus erythematosus tumidus.
Bohelay G; Rousset L; Levy A; Arana R; Laroche L; Caux F
Eur J Dermatol; 2017 Oct; 27(5):542-543. PubMed ID: 28691689
[No Abstract] [Full Text] [Related]
13. Pustuloderma during cutaneous lupus treatment with thalidomide.
Rúa-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernández G; Rodriguez-Lozano C; De la Rosa P
Lupus; 1999; 8(3):248-9. PubMed ID: 10342720
[No Abstract] [Full Text] [Related]
14. Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.
Geraminejad P; Stone MS; Sontheimer RD
Lupus; 2004; 13(6):473-7. PubMed ID: 15303576
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine-quinacrine association in resistant cutaneous lupus.
Lipsker D; Piette JC; Cacoub P; Godeau P; Frances C
Dermatology; 1995; 190(3):257-8. PubMed ID: 7599397
[No Abstract] [Full Text] [Related]
16. [Thiazide diuretic-induced subacute cutaneous lupus erythematosus].
Wollenberg A; Meurer M
Hautarzt; 1991 Nov; 42(11):709-12. PubMed ID: 1837545
[No Abstract] [Full Text] [Related]
17. Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicin.
Chen JK; Chen TS; Lim P; Iqbal M
J Am Acad Dermatol; 2012 Dec; 67(6):e273-5. PubMed ID: 23158635
[No Abstract] [Full Text] [Related]
18. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
[TBL] [Abstract][Full Text] [Related]
19. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
Wee JS; Natkunarajah J; Marsden RA
Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
[No Abstract] [Full Text] [Related]
20. Omeprazole-induced subacute cutaneous lupus erythematosus.
Mankia SK; Rytina E; Burrows NP
Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
